2026-07-23 · Finance · Accounting · Decision-Making · 8 min read
9 things a company's management discussion and analysis tells you that the financial statements never will
Every annual report contains two documents in one. The first is the audited financial statements — numbers that have been scrubbed, reconciled, and signed off. The second is the MD&A: management's own explanation of what happened and why. Most readers skim it. That is a mistake. The MD&A is where executives are required to say things the income statement cannot say — and where the gap between what they emphasize and what the numbers show tells you more than either source alone.
1. Which risks management actually believes are material
The risk factors section of a 10-K is often boilerplate — a legal team's attempt to disclaim everything. The MD&A is different. When management discusses a specific risk in the MD&A narrative, they are signaling that it is live, not theoretical. A company that mentions foreign-exchange exposure in the risk factors but then quantifies a $47 million translation loss in the MD&A is telling you the risk already landed. Watch for risks that migrate from boilerplate into the narrative year over year — that migration is the signal.
2. The real driver of revenue growth — or decline
Revenue on the income statement is a single line. The MD&A is required to disaggregate it. Under SEC rules, management must explain material changes in revenue by volume, price, and mix. A company that grew revenue 12% but achieved that entirely through price increases — not unit growth — is in a different position than one that grew 12% on volume alone. Price-driven growth can reverse the moment a competitor cuts. Volume-driven growth compounds. The MD&A tells you which one you are looking at; the income statement does not.
Look specifically for the phrase 'favorable pricing environment.' It often means the company raised prices faster than costs — and it raises the question of whether that environment persists. Tesco, for example, disclosed in its FY2023 MD&A that volume declined even as revenue rose, a signal that customers were trading down. That nuance was invisible at the consolidated revenue line.
3. Whether margin improvement is structural or temporary
Gross margin can expand for two distinct reasons: the company got better at its business, or input costs fell temporarily. The MD&A is where management is obligated to explain which one drove the result. A manufacturer that reports a 200-basis-point gross margin improvement because steel prices dropped is not the same business as one that improved margins through a redesigned supply chain. The first will give the margin back when commodity prices recover. The second will not. Read the MD&A cost discussion before you model forward margins.
4. What management chose not to discuss — and why that matters
Omission is a signal. If a company's largest segment underperformed and the MD&A spends three paragraphs on a smaller segment that beat expectations, that asymmetry is deliberate. Executives are not required to bury bad news, but they are human — they allocate narrative space to results they want you to focus on. A useful discipline: before reading the MD&A, calculate which segments or metrics moved most materially. Then check whether the MD&A addresses them proportionally. A mismatch between materiality and narrative space is worth investigating.
This technique is sometimes called 'narrative emphasis analysis.' Academic research — including work by Merkl-Davies and Brennan published in the British Accounting Review — documents that managers systematically over-discuss positive outcomes and under-discuss negative ones. You do not need a regression to apply this. You need a highlighter and a ratio.
5. The liquidity picture management expects over the next 12 months
The balance sheet shows liquidity at a point in time. The MD&A liquidity section is forward-looking. Management is required to disclose known commitments, expected capital expenditures, and whether they believe existing resources are sufficient to meet obligations for the next 12 months. When that language weakens — from 'we believe our resources are sufficient' to 'we may need to access capital markets' — that is a material shift. It often appears in the MD&A quarters before it appears in a credit rating action or a covenant waiver request.
Bed Bath & Beyond's 2022 10-K MD&A contained language about 'substantial doubt' regarding its ability to continue as a going concern. The stock still traded above $5 when that language appeared. Readers who parsed the MD&A liquidity section had a materially different information set than those who looked only at the income statement.
6. How management defines its own success — and whether the definition shifted
Companies choose which metrics to highlight in the MD&A. When those metrics change year over year, ask why. A software company that emphasized annual recurring revenue for three years and then shifted to 'total contract value' in its MD&A may be signaling that ARR growth slowed. A retailer that dropped same-store sales from its MD&A discussion and replaced it with 'total ecosystem revenue' is reframing a metric that deteriorated. The financial statements do not change the metric — the MD&A does. That change is the tell.
This is distinct from a legitimate business model evolution. The test is whether the new metric is more or less directly tied to cash generation than the old one. Metrics that move further from cash — toward engagement, ecosystem, or community — deserve more scrutiny, not less.
7. The actual capital expenditure plan — and what it implies about growth confidence
Capital expenditure guidance in the MD&A is one of the most underread forward signals in any annual report. When a company guides capex materially higher than the prior year, management is betting that demand will be there to absorb the new capacity. When capex guidance drops sharply, management is conserving cash — often because they expect demand to soften. Neither signal appears in the income statement. Both appear in the MD&A. Samsung's 2023 MD&A disclosed a significant reduction in memory chip capex before the market had fully priced the inventory correction in that segment.
8. The legal and regulatory exposure that is not yet a liability
Contingent liabilities on the balance sheet represent losses that are probable and estimable. The MD&A legal proceedings section covers a broader universe — matters that are reasonably possible but not yet probable, and matters where the range of loss cannot be estimated. These items do not appear as balance sheet liabilities. They appear only in the MD&A and footnotes. A company facing a €2 billion antitrust investigation in the EU may carry zero on its balance sheet if the outcome is uncertain — but the MD&A will disclose the proceeding. Readers who stop at the balance sheet miss it entirely.
The practical discipline: search the MD&A for the words 'reasonably possible,' 'cannot estimate,' and 'adverse outcome.' Each phrase marks an exposure that accounting rules do not require to be quantified but that could be material. This is not alarmism — most contingencies resolve favorably. But the asymmetry of outcomes means they deserve explicit attention.
9. Whether management's tone is consistent with the numbers — or running ahead of them
Tone analysis is not soft analysis. When management uses words like 'momentum,' 'accelerating,' and 'inflection' in the MD&A while the underlying metrics show deceleration, that gap is a quantifiable signal. You can measure it: list the forward-looking adjectives management uses, then check whether the trailing 4 quarters of the relevant metric support each one. A company describing 'strong demand signals' while inventory builds and days-sales-outstanding rises is telling two different stories simultaneously. The numbers are the more reliable narrator.
This discipline applies globally. Volkswagen's pre-Dieselgate MD&A filings used language about 'industry-leading quality systems' that was inconsistent with internal test data that later became public. The financial statements were technically accurate. The MD&A tone was not. Reading both together — and stress-testing the tone against the numbers — is the practitioner's edge that no screener provides.
What You’ll Learn
- How to extract forward-looking signals from the MD&A that audited financials cannot contain
- The specific language patterns that indicate deteriorating liquidity before a credit event
- How to identify metric substitution — when management quietly changes what it measures and why
- A repeatable framework for comparing MD&A tone against trailing financial data
- Which MD&A disclosures carry legal weight and which are discretionary — and how to tell the difference
A Note on What This Course Is — and Isn’t
We don’t pursue CE accreditation. The courses are pure education, not credentialing.
Nothing in this course constitutes personalized financial, legal, or investment advice. You’ll learn frameworks and analytical tools — what you do with them is your decision.
We use AI heavily and we’re transparent about it.
$189 per course. $504 for the bundle of three.
100% refund within 3 days of enrollment AND zero module access. Accessing any module — even briefly — waives the right to a refund permanently. Decisions are final; no appeals.
Instructor: Kareem — DBA International Business · MS Applied Economics & Predictive Analytics · MBA Finance & Accounting · Series 65 · university-level instructor since 2014.
— Dr. Kareem Tannous